A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age

OBJECTIVE Differences in diagnostic criteria and methods have led to mixed results regarding the metabolite pattern of HIV-associated brain injury in relation to neurocognitive impairment. Therefore, a multicenter MRS consortium was formed to evaluate the neurometabolites in HIV patients with or without cognitive impairment. METHODS Proton magnetic resonance spectroscopy (MRS) at short-echo time (30 ms) was assessed in the frontal white matter, basal ganglia, and parietal cortex of 100 HIV patients [61 with AIDS dementia complex (ADC) and 39 neuroasymptomatic (NAS)] and 37 seronegative (SN) controls. RESULTS Compared to SN, NAS had higher glial marker myoinositol-to-creatine ratio (MI/Cr) in the white matter (multivariate analyses, adjusted P=0.001), while ADC showed further increased MI/Cr in the white matter and basal ganglia (both P<0.001), and increased choline compounds (Cho)/Cr in white matter (P=0.04) and basal ganglia (P<0.001). Compared to NAS, ADC showed a reduction in the neuronal marker N-acetyl compound (NA)/Cr in the frontal white matter (P=0.007). CSF, but not plasma, viral load correlated with MI/Cr and Cho/Cr in white matter and NAA/Cr in parietal cortex. HIV infection and aging had additive effects on Cho/Cr and MI/Cr in the basal ganglia and white matter. CONCLUSIONS The results suggest that glial activation occurs during the NAS stages of HIV infection, whereas further inflammatory activity in the basal ganglia and neuronal injury in the white matter is associated with the development of cognitive impairment. Aging may further exacerbate brain metabolites associated with inflammation in HIV patient and thereby increase the risk for cognitive impairment.

[1]  Leo L. Cheng,et al.  Early brain injury in the SIV–macaque model of AIDS , 2000, AIDS.

[2]  G. Alexander,et al.  High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study. , 1999, The American journal of psychiatry.

[3]  S. Strother,et al.  The metabolic pathology of the AIDS dementia complex , 1987, Annals of neurology.

[4]  H. Möller,et al.  Metabolic characterization of AIDS dementia complex by spectroscopic imaging , 1999 .

[5]  Norbert Schuff,et al.  Age-related metabolite changes and volume loss in the hippocampus by magnetic resonance spectroscopy and imaging☆ , 1999, Neurobiology of Aging.

[6]  I. Wilkinson,et al.  A multicenter proton magnetic resonance spectroscopy study of neurological complications of AIDS. , 1996, AIDS research and human retroviruses.

[7]  E. Masliah,et al.  Spectrum of human immunodeficiency virus–associated neocortical damage , 1992, Annals of neurology.

[8]  D. Leibfritz,et al.  Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. , 1993, Developmental neuroscience.

[9]  V. Calvez,et al.  Clinical and spectroscopic improvement in HIV-associated cognitive impairment , 2001, Neurology.

[10]  T. Ernst,et al.  Elimination of artifacts in short echo time 1H MR spectroscopy of the frontal lobe , 1996, Magnetic resonance in medicine.

[11]  I. Wilkinson,et al.  Localized cerebral proton MR spectroscopy in HIV infection and AIDS. , 1994, AJNR. American journal of neuroradiology.

[12]  J J Mallet,et al.  Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study. , 2001, AJNR. American journal of neuroradiology.

[13]  L. Chang,et al.  Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex , 1999, Neurology.

[14]  G. Fein,et al.  Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV patients , 1999, Neurology.

[15]  D. Karnofsky.  The clinical evaluation of chemotherapeutic agents in cancer , 1949 .

[16]  R. Lenkinski,et al.  Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with imaging and clinical correlation. , 1993, Radiology.

[17]  J. Catalan,et al.  Cerebral proton magnetic resonance spectroscopy in asymptomatic HIV infection , 1997, AIDS.

[18]  I. Grant,et al.  Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome , 1997, Annals of neurology.

[19]  S. Holm.  A Simple Sequentially Rejective Multiple Test Procedure , 1979 .

[20]  T. Kemper,et al.  Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation: Pathogenetic relationship to the acquired immunodeficiency syndrome dementia complex , 1999, Annals of neurology.

[21]  Linda Chang,et al.  Effect of aging on brain metabolism in antiretroviral-naive HIV patients , 2004, AIDS.

[22]  I. Wilkinson,et al.  Short echo time proton spectroscopy of the brain in HIV infection/AIDS. , 1995, Magnetic resonance imaging.

[23]  J. Hennig,et al.  HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. , 1996, Radiology.

[24]  D J Jenden,et al.  In vivo proton magnetic resonance spectroscopy of the normal aging human brain. , 1996, Life sciences.

[25]  R. Price,et al.  The AIDS dementia complex. , 1988, The Journal of infectious diseases.

[26]  P. Lantos,et al.  A Review of Neuronal Damage in Human Immunodeficiency Virus Infection: Its Assessment, Possible Mechanism and Relationship to Dementia , 1993, Journal of neuropathology and experimental neurology.

[27]  O. Selnes,et al.  Clinical‐neuropathologic correlation in HIV‐associated dementia , 1993, Neurology.

[28]  H. Hefter,et al.  Potential time course of human immunodeficiency virus type 1-associated minor motor deficits: electrophysiologic and positron emission tomography findings. , 2000, Archives of neurology.

[29]  A. Guimarães,et al.  Increased cerebral blood volume in HIV‐positive patients detected by functional MRI , 1998, Neurology.

[30]  P. Barker,et al.  AIDS dementia complex: evaluation with proton MR spectroscopic imaging. , 1995, Radiology.

[31]  H. Clifford Lane,et al.  HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies , 1997, Nature Medicine.

[32]  J. Cuzick,et al.  A Wilcoxon-type test for trend. , 1985, Statistics in medicine.

[33]  Clyde Young Kramer,et al.  Extension of multiple range tests to group means with unequal numbers of replications , 1956 .

[34]  M W Weiner,et al.  Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging , 2001, Magnetic resonance in medicine.

[35]  Linda Chang.  In Vivo Magnetic Resonance Spectroscopy in HIV and HIV-Related Brain Diseases , 1995, Reviews in the neurosciences.

[36]  J R Griffiths,et al.  Aging of the adult human brain: In vivo quantitation of metabolite content with proton magnetic resonance spectroscopy , 1999, Journal of magnetic resonance imaging : JMRI.

[37]  F. Turkheimer,et al.  Selection of an Adaptive Test Statistic for Use with Multiple Comparison Analyses of Neuroimaging Data , 2000, NeuroImage.

[38]  A. Saykin,et al.  Proton spectroscopy in asymptomatic HIV-infected adults: initial results in a prospective cohort study. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[39]  G. Fein,et al.  Reduced brain N‐acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus‐seropositive individuals , 1993, Neurology.

[40]  G. Fein,et al.  Deep gray matter structures in HIV infection: a proton MR spectroscopic study. , 1996, AJNR. American journal of neuroradiology.

[41]  J. Becker,et al.  Neuropsychological performance in HIV‐1‐infected homosexual men , 1990, Neurology.

[42]  D. Eidelberg,et al.  Brain lactate and N-acetylaspartate in pediatric AIDS encephalopathy. , 1998, AJNR. American journal of neuroradiology.

[43]  D. Cox,et al.  An Analysis of Transformations , 1964 .

[44]  Stuart A. Lipton,et al.  Pathways to neuronal injury and apoptosis in HIV-associated dementia , 2001, Nature.

[45]  H. Gendelman,et al.  Prospective utility of cerebral proton magnetic resonance spectroscopy in monitoring HIV infection and its associated neurological impairment. , 1994, AIDS research and human retroviruses.

[46]  K. Ruxrungtham,et al.  Magnetic resonance spectroscopy of the brain in neurologically asymptomatic HIV-infected patients. , 2000, Magnetic resonance imaging.

[47]  E. Masliah,et al.  Neocortical damage during HIV infection , 1991, Annals of neurology.

[48]  L. Chang,et al.  Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia , 1999, Neurology.

[49]  O. Selnes,et al.  Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors. , 2000, Journal of neurovirology.

[50]  Cheuk Y. Tang,et al.  A multi‐center 1H MRS study of the AIDS dementia complex: Validation and preliminary analysis , 2003, Journal of magnetic resonance imaging : JMRI.

[51]  S C Strother,et al.  Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[52]  Linda Chang,et al.  Relationships among Brain Metabolites, Cognitive Function, and Viral Loads in Antiretroviral-Naı̈ve HIV Patients , 2002, NeuroImage.

[53]  G. Satten,et al.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. , 1998, The New England journal of medicine.

[54]  T Ernst,et al.  Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. , 1997, Radiology.

[55]  P. Easterbrook,et al.  1H MR Spectroscopy of the Brain in HIV-1-Seropositive Subjects: Evidence for Diffuse Metabolic Abnormalities , 1998, Metabolic Brain Disease.

[56]  I. Wilkinson,et al.  Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. , 1993, Radiology.

[57]  H. Hefter,et al.  Basal ganglia metabolite abnormalities in minor motor disorders associated with human immunodeficiency virus type 1. , 2001, Archives of neurology.

[58]  B. Navia,et al.  The AIDS dementia complex: I. Clinical features , 1986, Annals of neurology.

[59]  J. Vion-Dury,et al.  Brain proton magnetic resonance spectroscopy in HIV-related encephalopathy: identification of evolving metabolic patterns in relation to dementia and therapy. , 1997, AIDS research and human retroviruses.

[60]  A. Guimarães,et al.  Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex , 1996, Neurology.

[61]  J. McArthur,et al.  Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brain , 1997, Annals of neurology.

[62]  G. Fein,et al.  N-acetylaspartate reductions measured by 1H MRSI in cognitively impaired HIV-seropositive individuals. , 1994, Magnetic resonance imaging.

[63]  O. Selnes,et al.  Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men , 1999, Neurology.

[64]  I. Wilkinson,et al.  Proton MRS and quantitative MRI assessment of the short term neurological response to antiretroviral therapy in AIDS , 1997, Journal of neurology, neurosurgery, and psychiatry.

[65]  R. Poland,et al.  Proton spectroscopy in myotonic dystrophy: correlations with CTG repeats. , 1998, Archives of neurology.

[66]  R. Lenkinski,et al.  Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[67]  J. Glass,et al.  Immunocytochemical quantitation of human immunodeficiency virus in the brain: Correlations with dementia , 1995, Annals of neurology.

[68]  B. Navia,et al.  The AIDS dementia complex: II. Neuropathology , 1986, Annals of neurology.